TriSalus Life Sciences
TLSI
TLSI
49 hedge funds and large institutions have $46.8M invested in TriSalus Life Sciences in 2025 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 17 increasing their positions, 2 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
12.64% more ownership
Funds ownership: 10.06% → 22.7% (+13%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
49
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$10.9M | |
| 2 | +$6.81M | |
| 3 | +$3.22M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$3.04M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.79M |
Top Sellers
| 1 | -$562K | |
| 2 | -$147K | |
| 3 | -$112K | |
| 4 |
Goldman Sachs
New York
|
-$93.1K |
| 5 |
Lido Advisors
Los Angeles,
California
|
-$78.4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Renaissance Technologies
New York
| – |
|
|||
|
52
Lido Advisors
Los Angeles,
California
| – |
|
|||
|
HF
53
HRT Financial
New York
| – |
|
|||
54
Balyasny Asset Management
Chicago,
Illinois
| – |
|
|||
|
TSS
55
Two Sigma Securities
New York
| – |
|
|||
56
Prudential Financial
Newark,
New Jersey
| – |
|
|||
|
CCM
57
Coldstream Capital Management
Bellevue,
Washington
| – |
|